Multivariate risk preferences in the quality-adjusted life year model

Arthur E. Attema, Jona J. Frasch and Olivier L’haridon ()
Additional contact information
Arthur E. Attema: Erasmus School of Health Policy and Management |Rotterdam]
Jona J. Frasch: Erasmus School of Health Policy and Management |Rotterdam]
Olivier L’haridon: CREM - Centre de recherche en économie et management - UNICAEN - Université de Caen Normandie - NU - Normandie Université - UR - Université de Rennes - CNRS - Centre National de la Recherche Scientifique
Authors registered in the RePEc Author Service: Olivier L'Haridon

Post-Print from HAL

Abstract: The interest in multivariate and higher-order risk preferences has increased. A growing body of literature has demonstrated the relevance and impact of these preferences, but for health the evidence is lacking. We measure multivariate and higher-order risk preferences for quality of life (QoL) and longevity, the two attributes of the Quality-Adjusted Life Year (QALY) model. We observe preferences for a positive correlation between these attributes and for pooling together a fixed loss in one of the attributes and a mean-zero risk in the other, and for pooling together mean-zero risks in QoL and longevity. The findings indicate that higher-order risk preferences are stronger for health than for money. Furthermore, we test if preferences for a risky treatment for a disease affecting only QoL, depend on life expectancy. We find no such a relation, but there is a positive relation between riskiness of a comorbidity affecting life expectancy and risk aversion for a QoL treatment. We therefore observe no definitive deviation from the QALY model, although the model is more robust when expected longevity is high. Our findings suggest that the current practice of cost-effectiveness analysis should be generalized to account for risk aversion in QoL and longevity, and higher-order preferences.

Keywords: comorbidities; correlation attitude; prudence; QALYs; risk apportionment; risk aversion; temperance; treatment intensity (search for similar items in EconPapers)
Date: 2022-02
New Economics Papers: this item is included in nep-hea, nep-rmg and nep-upt
Note: View the original document on HAL open archive server: https://hal.science/hal-03469162
References: View references in EconPapers View complete reference list from CitEc
Citations:

Published in Health Economics, 2022, 31 (2), pp.382-398. ⟨10.1002/hec.4456⟩

Downloads: (external link)
https://hal.science/hal-03469162/document (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-03469162

DOI: 10.1002/hec.4456

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().